Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 05, 2026 3.696
October 02, 2026 3.729
October 01, 2026 3.760
September 30, 2026 3.807
September 29, 2026 3.798
September 28, 2026 3.808
September 25, 2026 3.797
September 24, 2026 3.803
September 23, 2026 3.761
September 22, 2026 3.818
September 21, 2026 3.812
September 18, 2026 3.810
September 17, 2026 3.844
September 16, 2026 3.814
September 15, 2026 3.814
September 14, 2026 3.852
September 11, 2026 3.824
September 10, 2026 3.833
September 09, 2026 3.953
September 08, 2026 3.953
September 04, 2026 4.172
September 03, 2026 4.167
September 02, 2026 4.117
September 01, 2026 4.066
August 31, 2026 4.006
Date Value
August 28, 2026 3.970
August 27, 2026 4.040
August 26, 2026 4.032
August 25, 2026 4.049
August 24, 2026 4.001
August 21, 2026 4.000
August 20, 2026 3.952
August 19, 2026 4.027
August 18, 2026 3.894
August 17, 2026 3.878
August 14, 2026 3.823
August 13, 2026 3.820
August 12, 2026 3.863
August 11, 2026 3.77
August 10, 2026 3.782
August 07, 2026 3.704
August 06, 2026 3.735
August 05, 2026 3.767
August 04, 2026 3.750
August 03, 2026 3.730
July 31, 2026 3.812
July 30, 2026 3.850
July 29, 2026 3.861
July 28, 2026 3.912
July 27, 2026 3.831

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
AstraZeneca PLC 10.26
Johnson & Johnson 7.168
Merck & Co., Inc. 8.215
Viatris, Inc. 1.427
ANI Pharmaceuticals, Inc. 2.792

Price to Book Value Related Metrics